U.S. Personal Products Stock News

Why EQT (EQT) is on investors’ radar EQT (EQT) has drawn investor attention after recent trading left the stock with a 1 day return of 2.4% and a past month return of 6.3%, compared with a 19.3% total return over the past year. See our latest analysis for EQT. At a share price of US$59.03, EQT’s recent swingy pattern, including a 6.3% 30 day share price return alongside a 10.4% year to date share price return, contrasts with a much stronger 5 year total shareholder return of 241.7%. This...

Keurig Dr Pepper recently expanded its 2026 innovation slate with more than 35 new beverage varieties across carbonated soft drinks, teas, waters, energy and juice drinks, while also refreshing legacy brands like Snapple and Canada Dry Fruit Splash Strawberry. At the same time, the company is reshaping its governance and business mix ahead of earnings by adding two experienced independent directors, progressing toward the JDE Peet’s acquisition and planning a separation into Beverage Co. and...

If you are wondering whether Allegro MicroSystems is fairly priced or not, this article explains what the current share price might be implying about its value. The stock recently closed at US$38.48, with returns of 16.6% over the last 30 days, 43.0% year to date and 53.9% over the past year. Over the last 7 days it declined 9.2%, and the 3 year return sits at a 10.4% decline compared to 41.6% over 5 years. Recent coverage has focused on Allegro MicroSystems as a semiconductor company that...

Earlier in February 2026, Blue Bird reported quarterly sales and profits that exceeded expectations, highlighted growing order backlog and the delivery of 121 electric school buses. Analysts pointed to Blue Bird’s improving margin profile and its scarcity value in the specialty vehicle space following recent industry M&A as key positives. Now we’ll examine how these stronger-than-expected results, particularly the momentum in electric bus deliveries, may influence Blue Bird’s investment...

Jazz Pharmaceuticals marked World Cholangiocarcinoma Day by supporting awareness efforts for this rare bile duct cancer. The company highlighted patient stories and advocacy partnerships as part of its rare disease engagement. This outreach focuses on education around cholangiocarcinoma, a condition that often receives limited public attention. For investors watching Jazz Pharmaceuticals, ticker NasdaqGS:JAZZ, this awareness push sits alongside a current share price of $173.25 and a 1-year...

Dominion Energy (D) has laid out its FY 2025 scorecard with third quarter revenue of US$4.5b and basic EPS of US$1.17, capped by trailing twelve month revenue of US$16.5b and EPS of US$3.47 that sit against a 60.5% year over year earnings jump and a 5.7% five year average earnings growth rate. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$4.1b in Q1 2025, US$3.8b in Q2 2025 and US$4.5b in Q3 2025. Basic EPS shifted from a Q4 2024 loss of US$0.13 per share to...

Kinetik Holdings (NYSE:KNTK) is reported to be exploring a potential sale process. Western Midstream Partners has shown interest in a possible acquisition of Kinetik Holdings. The situation points to possible changes in ownership structure and future direction for the company. Kinetik Holdings, listed on the NYSE under ticker KNTK, operates in the midstream energy space, connecting upstream production with downstream demand through gathering, processing, and related services. Attention on...

Watsco (NYSE:WSO) announced that its Board of Directors approved a 10% increase in its annual dividend. The decision represents a material change in the company’s capital return to shareholders. Watsco, a large distributor of air conditioning, heating and refrigeration equipment, sits at the crossroads of residential and commercial demand for climate systems. For income focused investors, a 10% increase in the annual dividend is a meaningful signal about how the Board views the company’s...

Recent analyst upgrades have pushed CBRE Group (CBRE) back into focus, with firms citing the company’s position in commercial real estate and its guidance for meaningful growth even as AI related fee worries linger. See our latest analysis for CBRE Group. CBRE’s shares have pulled back recently, with a 30 day share price return of 14.8% and a year to date share price return of 10%. At the same time, the 1 year total shareholder return of 4.6% and 5 year total shareholder return of 85.9%...

What Recent Performance Says About Napco Security Technologies Without a fresh headline event to react to, Napco Security Technologies (NSSC) is still drawing interest as investors look at how its recent share performance lines up with its current fundamentals. See our latest analysis for Napco Security Technologies. The recent share price return tells a story of building momentum, with Napco Security Technologies posting a 19.05% 1 month share price return and a 1 year total shareholder...

Dole's Colada Royale Pineapple has been named a 2026 Best New Product Awards Winner by BrandSpark International and Newsweek. The recognition highlights Dole's focus on product development within the fresh produce category. The award spotlights Colada Royale Pineapple as a differentiated offering in Dole's portfolio. Dole (NYSE:DOLE) operates across the fresh fruit and vegetable value chain, so a branded product win in a consumer awards program speaks directly to how its R&D and marketing...

Crinetics Pharmaceuticals (NasdaqGS:CRNX) reported positive clinical trial results for its congenital adrenal hyperplasia treatment. The company also announced positive initial sales for its oral therapy for acromegaly, alongside progress on related regulatory milestones. These updates highlight recent clinical and commercial developments in Crinetics' rare endocrine disease portfolio. Crinetics Pharmaceuticals focuses on therapies for rare endocrine conditions, an area where treatment...

What the latest earnings and buyback update means for Apollo Commercial Real Estate Finance (ARI) Apollo Commercial Real Estate Finance (ARI) just released fourth quarter and full year 2025 results, reporting quarterly income of US$29.2 million and a full year return to profitability, alongside the completion of a multi year share repurchase program. See our latest analysis for Apollo Commercial Real Estate Finance. The latest earnings rebound and completion of a multi year buyback sit...

The U.S. decision to impose a 15% global tariff for up to 150 days has put Starbucks (SBUX) in sharper focus, as investors reassess a business that is heavily tied to international sourcing and overseas operations. See our latest analysis for Starbucks. Despite the tariff headlines, Starbucks’ 90 day share price return of 10.32% and year to date share price return of 12.87% point to improving momentum. However, the 1 year total shareholder return decline of 13.95% shows that longer term...

If you are wondering whether Xcel Energy's current share price offers good value, this article will walk through what the numbers are saying about the stock today. Xcel Energy shares recently closed at US$83.35, with returns of 2.2% over 7 days, 11.1% over 30 days, 11.6% year to date, 21.6% over 1 year, 41.3% over 3 years and 65.1% over 5 years. This gives useful context before looking at valuation. Recent news around Xcel Energy has focused on its role as a regulated utility and how...

If you are wondering whether Service Corporation International's current share price lines up with its underlying value, this article will walk through what the data is actually saying about the stock. The shares recently closed at US$79.45, with returns of a 0.3% decline over the last 7 days, a 2.1% decline over 30 days, a 2.9% gain year to date, 1.3% over 1 year, 22.4% over 3 years and 74.4% over 5 years, which gives useful context before comparing that price to different valuation...

Boise Cascade (BCC) has drawn fresh attention after recent trading left the shares with a year-to-date total return of 8.7% and a 1-year total return decline of 21.5%. See our latest analysis for Boise Cascade. Recent trading has been weak, with a 7 day share price return of 6.9% and a 30 day share price return of 4.5%. However, the year to date share price return of 8.7% contrasts with a 1 year total shareholder return decline of 21.5%, while the 5 year total shareholder return of 103.8%...

If you are wondering whether MakeMyTrip at around US$55 a share still offers value, the key question is how its current price compares with what the business might reasonably be worth. The stock has seen mixed returns, with a 1.7% decline over the last week, an 11.7% decline over the last month, a 32.5% decline year to date, but a 118.8% gain over three years and a 54.0% gain over five years. These shifts can change how the market views both its growth potential and its risk profile. Recent...

For investors wondering whether MKS at around US$253 a share is still a worthwhile entry, or if most of the value is already on the table, this article walks through what the numbers currently suggest. The stock has been volatile over different time frames, with a 2.7% decline over the last 7 days, a 16.9% return over 30 days, a 50.7% return year to date and a 155.8% return over the past year, while the 3 year and 5 year returns sit at 182.0% and 53.5% respectively. Recent coverage around...

Steel Dynamics, together with SGH Ltd, has submitted a revised joint bid to acquire BlueScope Steel's North American operations. The proposed deal would enlarge Steel Dynamics' North American presence in flat-rolled and value-added steel products. Corporate Knights has again named Steel Dynamics as the global leader in steel industry sustainability, reflecting its circular manufacturing model. For investors watching NasdaqGS:STLD, these updates come as the stock trades around $196.01, with...

Wondering whether Innospec's current share price still reflects its underlying worth, or if the market is mispricing it, is a fair question for anyone tracking specialty chemicals stocks. Over the past week the stock has recorded a 8.8% decline, with a 2.3% decline over 30 days, a 3.5% gain year to date, and a 20.9% decline over one year, while the three and five year returns stand at 25.8% and 16.4% declines respectively. These moves have kept Innospec on the radar of investors who are...

CRH (NYSE:CRH) completed more than three dozen acquisitions in 2025. The company acquired Eco Material Technologies, described as a transformative deal for its portfolio. Management is preparing for expected strength in U.S. infrastructure spending in 2026, including state and federal highway projects. CRH, a major player in construction materials and solutions, is using acquisitions to build out its U.S. footprint and broaden its mix of products and services. The Eco Material Technologies...

Capricor Therapeutics recently advanced its lead candidate Deramiocel into phase 3 trials for Duchenne muscular dystrophy while progressing preclinical work on its exosome-based SARS-CoV-2 vaccine and StealthX exosome platform. This pipeline momentum, coupled with unanimous positive analyst coverage, highlights how central Deramiocel and exosome technologies have become to the company’s long-term thesis. Next, we’ll examine how Deramiocel’s phase 3 progress and upbeat analyst sentiment feed...

T. Rowe Price Group (TROW) has attracted fresh attention after recent share price weakness, with the stock showing negative returns over the month and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for T. Rowe Price Group. At a share price of $93.06, T. Rowe Price Group has seen a 1 day share price return of 2.43% decline and a 30 day share price return of 11.90% decline, while its 1 year total shareholder return of 8.04%...